指南与共识颈动脉与弓上血管

透析依赖的无症状颈动脉疾病患者颈动脉血运重建的围手术期结局符合血管外科学会指南

Perioperative outcomes for carotid revascularization on asymptomatic dialysis-dependent patients meet Society for Vascular Society guidelines.
指南 / 共识 · J Vasc Surg · 2020-12-17

本研究基于ACS NSQIP血管模块2011-2018年数据,比较透析依赖与非透析的无症状颈动脉疾病患者颈动脉血运重建的30天结局。透析依赖患者占1.3%,其卒中/死亡复合结局为2.2%,符合SVS指南围手术期卒中/死亡<3%的推荐,提示对经选择的透析依赖患者可考虑颈动脉血运重建。

要点

  • 透析依赖的无症状颈动脉疾病患者颈动脉血运重建30天卒中/死亡率为2.2%,符合SVS指南<3%的标准。
  • 透析依赖患者合并症更多但更年轻,围手术期卒中、死亡、心梗发生率与非透析患者无显著差异。
  • 多变量分析显示透析依赖与卒中/死亡复合结局无独立关联,但置信区间宽,结论需谨慎。

核心结论

  • 透析依赖的无症状颈动脉疾病患者颈动脉血运重建的30天结局符合SVS指南,可能优于既往推测。
  • 对预期寿命合适且围手术期风险可接受的经选择透析依赖患者,血管外科医生可考虑颈动脉血运重建。

研究设计与样本

  • 回顾性队列研究,查询ACS NSQIP靶向血管模块2011-2018年数据。
  • 纳入17,579例因无症状颈动脉疾病行颈动脉内膜切除术或颈动脉支架置入术的患者。
  • 按是否依赖透析分为透析组(226例,1.3%)和非透析组。

主要发现

  • 透析组与非透析组严重狭窄(80%-99%)比例分别为69%和72%(P=.9),颈动脉支架置入比例分别为5%和3.6%(P=.3)。
  • 透析组更年轻(68 vs 71岁,P<.001),胰岛素依赖糖尿病(47% vs 12%,P<.001)、充血性心力衰竭(8.4% vs 1.4%,P<.001)和严重COPD(15% vs 10%,P=.03)比例更高。
  • 透析组与非透析组30天死亡(0.9% vs 0.5%,P=.3)、卒中(1.8% vs 1.4%,P=.6)、心梗(1.3% vs 1.1%,P=.5)无显著差异。
  • 卒中/死亡复合结局分别为2.2%和1.8%(P=.6),卒中/死亡/心梗复合结局分别为3.5%和2.8%(P=.4)。
  • 多变量分析中,eGFR(aOR 1.0,95%CI 1.00-1.01,P=.26)和透析依赖(aOR 0.21,95%CI 0.03-1.57,P=.13)与卒中/死亡复合结局无独立关联。

关键数值与推荐

  • SVS指南推荐:对预期寿命至少3年、狭窄>60%且预期围手术期卒中/死亡<3%的无症状患者行颈动脉血运重建。
  • 本研究透析依赖患者30天卒中/死亡复合结局为2.2%,符合上述<3%的围手术期阈值。

临床怎么用

  • 对于经选择的透析依赖无症状颈动脉疾病患者,若预期寿命合适且围手术期风险可接受,可考虑颈动脉血运重建。
  • 决策时应综合评估合并症(如胰岛素依赖糖尿病、心衰、严重COPD)及围手术期风险。

局限性

  • 回顾性研究设计,可能存在选择偏倚和未测量混杂。
  • 透析依赖患者样本量较小(226例),事件数少,多变量分析置信区间宽。
  • 仅评估30天围手术期结局,缺乏长期生存和卒中预防数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The current Society for Vascular Surgery practice guidelines recommend carotid revascularization for asymptomatic disease in patients with at least a 3-year life expectancy and stenosis >60% when the expected perioperative stroke and death rate is <3%. Based on this recommendation, it was previously determined that asymptomatic patients who require dialysis would not meet the perioperative stroke and death thresholds nor the long-term survival benchmarks to justify carotid surgery. To determine whether carotid surgery for patients requiring dialysis is appropriate, the present study compared the perioperative outcomes after carotid revascularization for dialysis-dependent patients relative to nondialysis patients in a contemporary, national cohort. METHODS: The targeted vascular module from the American College of Surgeons National Surgical Quality Improvement Program was queried to identify patients who undergone carotid endarterectomy or carotid artery stenting for asymptomatic carotid disease from 2011 to 2018. The cohort was categorized as requiring or not requiring dialysis. The primary 30-day outcomes included mortality and the composite of stroke/death and stroke/death/myocardial infarction (MI). Univariate analyses were performed using the Fisher exact test and Wilcoxon rank sum test. Multivariable analyses were used to assess the independent associations of the estimated glomerular filtration rate and dialysis dependence with the stroke/death rate. RESULTS: A total of 17,579 patients met the inclusion criteria. Of these patients, 226 (1.3%) required dialysis at revascularization. No difference was found in the degree of severe stenosis (80%-99%) demonstrated by 69% of the dialysis cohort and 72% of the nondialysis cohort (P = .9). Of the dialysis and nondialysis cohorts, 5% and 3.6% underwent carotid artery stenting (P = .3). The dialysis-dependent patients were younger (68 vs 71 years; P < .001) and were more likely to have insulin-dependent diabetes (47% vs 12%; P < .001), congestive heart failure (8.4% vs 1.4%; P < .001), and severe chronic obstructive pulmonary disease (15% vs 10%; P = .03). In the dialysis and nondialysis cohort, 2 (0.9%) and 88 (0.5%) patients died (P = .3); 4 (1.8%) and 247 (1.4%) experienced strokes (P = .6); and 3 (1.3%) and 185 (1.1%) patients experienced MI (P = .5), respectively. The composite outcomes of stroke/death and stroke/death/MI was 2.2% (n = 5) and 1.8% (n = 319; P = .6) and 3.5% (n = 8) and 2.8% (n = 479; P = .4) in the dialysis and nondialysis cohorts, respectively. After multivariable analysis, neither the estimated glomerular filtration rate (adjusted odds ratio, 1.0; 95% confidence interval, 1.00-1.01; P = .26) nor dialysis dependence (adjusted odds ratio, 0.21; 95% confidence interval, 0.03-1.57; P = .13) was independently associated with the composite outcome of stroke/death. CONCLUSIONS: The 30-day carotid revascularization outcomes for asymptomatic disease in dialysis-dependent patients met the Society for Vascular Surgery guidelines in this national cohort and might be better than previously surmised. Hence, vascular surgeons could consider carotid revascularization for select dialysis-dependent patients with the appropriate expected longevity and perioperative risk.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Latz CA, Boitano LT, Wang LJ, et al. Perioperative outcomes for carotid revascularization on asymptomatic dialysis-dependent patients meet Society for Vascular Society guidelines. J Vasc Surg. 2020. PMID: 33340696. doi:10.1016/j.jvs.2020.11.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。